Fiedler receives 2013 NIH Director's New Innovator Award
September 30, 2013. Washington, D.C. Dorothea Fiedler, Assistant Professor of Chemistry, is the recipient of one of seventy-eight grants being awarded to scientists proposing highly innovative approaches to major contemporary challenges in biomedical research, under the High Risk-High Reward program supported by the National Institutes of Health Common Fund.
"NIH is excited to continue support of visionary investigators, among all career stages, pursuing science with the potential to transform scientific fields and accelerate the translation of scientific research into improved health, through the Common Fund’s High Risk-High Reward Research Program. This Program allows researchers to propose highly creative research projects across a broad range of biomedical research areas, that involve inherent risk, but have the potential for high-rewards," said NIH Director Francis S. Collins, M.D., Ph.D.
Fiedler has been awarded a New Innovator Award, established in 2007, intended to support investigators who are within 10 years of their terminal degree or clinical residency, but who have not yet received a Research Project Grant (R01) or equivalent NIH grant, to conduct exceptionally innovative research.
The total funding of the 2013 High Risk-High Reward Research Awards, which represents contributions from the NIH Common Fund and multiple NIH institutes and centers, is approximately $123 million.